Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04770896 |
|---|---|
| Brief Title: | A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab (IMbrave251) |
| First Submitted : | February 23, 2021 |
| First Submitted that Met QC Criteria : | February 23, 2021 |
| First Posted : | February 25, 2021 |
| Last Update Submitted that Met QC Criteria : | March 20, 2024 |
| Last Update Posted : | March 21, 2024 |